ID: ALA553416
Chembl Id: CHEMBL553416
PubChem CID: 45269050
Max Phase: Preclinical
Molecular Formula: C15H14Cl2N2O
Molecular Weight: 309.20
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C(N)=O)c1ccccc1Nc1c(Cl)cccc1Cl
Standard InChI: InChI=1S/C15H14Cl2N2O/c1-9(15(18)20)10-5-2-3-8-13(10)19-14-11(16)6-4-7-12(14)17/h2-9,19H,1H3,(H2,18,20)
Standard InChI Key: RJQUTNJNKSGMHW-UHFFFAOYSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 309.20 | Molecular Weight (Monoisotopic): 308.0483 | AlogP: 4.33 | #Rotatable Bonds: 4 |
| Polar Surface Area: 55.12 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 2 |
| #RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
| CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 4.00 | CX LogD: 4.00 |
| Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.88 | Np Likeness Score: -0.85 |
| 1. Sablone MR, Cesta MC, Moriconi A, Aramini A, Bizzarri C, Di Giacinto C, Di Bitondo R, Gloaguen I, Aschi M, Crucianelli M, Bertini R, Allegretti M.. (2009) Structure-Activity Relationship of novel phenylacetic CXCR1 inhibitors., 19 (15): [PMID:19560921] [10.1016/j.bmcl.2009.06.027] |
Source(1):
